RPL34 and central nervous system cancer: For example, RPL34 is overexpressed in pancreatic cancer and glioma and in vitro cell culture studies have implicated RPL34 in promoting cell invasion through activation of MAPK, p53, and the JAK/STAT3 signaling pathways (Jiet al., 2019;Weiet al., 2016).